栓塞剂市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00025058
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 219
Buy Now

栓塞剂市场预计将从 2021 年的 27.1482 亿美元增至 2028 年的 45.2575 亿美元;预计2021年至2028年复合年增长率为7.6%。

市场的增长归因于肿瘤和动脉瘤发病率的上升以及高血压、肥胖、吸烟和酗酒患病率的上升。然而,栓塞剂的高成本限制了栓塞剂市场的增长。栓塞剂用于应用机械闭塞来阻止血管或血管区域中的血液流动。在介入放射学中,栓塞是一种常见的手术。栓塞手术主要用于治疗外伤。栓塞剂有多种形式,每种形式都有其自己的特性和应用。根据动脉闭塞所需的持续时间,栓塞剂分为临时性和永久性。

战略见解
在美国,由于治疗方式的转变,对疣治疗程序的需求有所减少。专注于 COVID-19 治疗。 COVID-19 大流行给全球供应链、消费市场和经济造成了严重破坏。这种情况导致亚太地区各国进行的心脏手术数量减少。世界各国政府实施的措施对栓塞剂市场的增长产生了负面影响。

栓塞剂市场利润丰厚的区域



市场洞察
肿瘤和动脉瘤发病率上升推动栓塞剂市场增长
根据美国国家癌症研究所的数据,2020 年,新发癌症病例 1,806,590 例,因癌症死亡 606,520 例美国的疾病。 2020 年,前列腺癌、肺癌和结直肠癌占男性诊断出的所有癌症的 43%。乳腺癌、肺癌和结直肠癌是女性最常见的三种癌症。根据脑动脉瘤基金会的统计与事实报告,在美国,大约有 650 万人(即每 50 人中就有 1 人)患有未破裂的脑动脉瘤。它还提到,在被诊断患有脑动脉瘤的总人数中,20% 患有多个动脉瘤。据报道,美国每年约有3万人患有脑动脉瘤破裂,每18分钟就会发生一次脑动脉瘤破裂。此外,根据 NHS 的数据,在英国,每年每 12,500 人中就有 1 人患有脑动脉瘤破裂。此外,根据“未破裂颅内动脉瘤发病机制和个体化管理” 2020年德国国际报发表的报告显示,德国约有200万人(成人)患有未破裂颅内动脉瘤(IA)。栓塞剂用于通过机械闭塞的方式急剧停止血管或血管区域中的流动。栓塞剂,例如栓塞微球(珠子),用于限制肿瘤的血管供应,并且可以装载化疗药物,这些药物洗脱并扩散到组织中。液体栓塞剂用于阻止动脉瘤或肿瘤的血液供应。因此,动脉瘤和癌症患病率的不断增加对栓塞剂产生了很高的需求。

基于产品的见解

根据产品,栓塞剂市场分为线圈、珠子/颗粒、栓塞、可拆卸球囊、胶水、海绵、液体栓塞剂、硬化剂、沉淀剂等。珠子/颗粒部分占据最大的市场份额。然而,卷材领域预计在 2021 年至 2028 年期间复合年增长率最高。弹簧圈栓塞是一种基于导管的手术,可以精确闭塞血管中的异常血流。心脏手术数量的增加正在推动该细分市场的市场增长。

栓塞剂市场(按产品) 2021年和2028年



基于应用的见解

根据应用,栓塞剂市场分为神经病学、肿瘤学、心脏病学、周围血管疾病等。肿瘤学领域占有最大的市场份额,预计在预测期内复合年增长率最高。

基于最终用户的见解

基于最终用户,栓塞剂市场分为医院、门诊手术中心、心脏中心等。医院细分市场占有最大的市场份额,预计在预测期内复合年增长率最高。该细分市场的市场增长归因于世界各地医院数量的增加和外科手术数量的快速增长。

在栓塞剂市场运营的公司正在采用产品创新策略来满足不断发展的需求世界各地的客户需求,这也使他们能够在全球市场上保持自己的品牌。

栓塞剂市场 –按产品

  • 线圈
    • 可拆卸线圈
    • 可推动线圈
  • 珠子/颗粒
    • 球形
    • 非球形
  • 插头
  • 可拆卸气球
  • 胶水
  • 胶水
  • li>
  • 海绵
  • 液体栓塞剂
  • 硬化剂
  • 沉淀剂
  • 其他

栓塞剂市场——按应用分类

  • 肿瘤学
  • 神经学
  • 泌尿学
  • 心脏病学
  • 周围血管疾病
  • 其他

栓塞剂市场 -按最终用户划分

  • 医院
  • 心脏中心
  • 门诊手术中心
  • 其他
< h3>栓塞剂市场–按地理位置
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • < li>欧洲
    • 法国
    • 德国
    • 意大利
    • 英国
    • 西班牙
    • 休息欧洲
  • 亚太地区 (APAC)
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳大利亚
    • 亚太地区其他地区
  • 中东和非洲 (MEA)
    • 南非
    • 沙特阿拉伯
    • 阿联酋
    • MEA其他地区
  • 南美洲和中美洲(SCAM )
    • 巴西
    • 阿根廷
    • 其他骗局

公司简介

  • 美敦力
  • 泰尔茂公司
  • 库克医疗有限责任公司
  • 波士顿科学公司
  • 雅培
  • < li>Stryker Corporation
  • Penumbra, Inc.
  • Merit Medical Systems Inc.
  • DePuy Synthes
  • KANEKA CORPORATION
  • < /ul>
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are embolization agents?

Embolization agents are used to apply mechanical occlusion to stop the flow of blood in a blood vessel or vascular area. In interventional radiology, embolization is a common procedure. Embolization procedures are most used to treat traumatic injuries. Embolic agents come in a variety of forms, each with its own set of properties and applications. Depending on the duration of time that arterial occlusion is required, embolization agents are classified as temporary or permanent.

What are the driving factors for the embolization agents market across the globe?

The factors that are driving growth of the market are rising incidence of tumors and aneurysms, and growing incidence of hypertension, obesity, smoking, and alcoholism.

Who are the developments carrying out by major players in the embolization agents market?

Various companies have made organic growth strategies in the embolization agents market. Some of the activities undertaken by the company, which have promoted its growth are, launches, enhancements and expansion & relocation activities. Companies such as Medtronic, Cook Medical LLC amongst others are some of the companies that have been implementing various organic strategies that have helped the growth of the company.

Which region is dominated the embolization agents market?

North America dominates the global embolization agents market due to factors such as increasing incidences of the neurological disorders such as stroke, brain aneurysms and others across the country, increasing product launches, well-developed healthcare facility centres equipped with modern-age equipment and instruments.

Which segment is growing at the highest CAGR in the embolization agents market?

The coil segment is growing at the highest CAGR owing to increasing number of cardiac surgeries.

Which region is the fastest growing in the embolization agents market?

Asia Pacific is expected to be the fastest growing region in the embolization agents market. The growth of the market in this region is primarily due to factors such as rising prevalence of the brain stroke, coronary artery diseases, heart diseases, increasing surgical procedures, growing number of hospitals and ambulatory surgeries centers, focus by industry players in Japan and developing healthcare infrastructure in India are likely to boost the market growth in forecast period.

The List of Companies - Embolization Agents Market

  1. Medtronic
  2. Terumo Corporation
  3. Cook Medical LLC
  4. Boston Scientific Corporation
  5. Abbott
  6. Stryker Corporation
  7. Penumbra, Inc.
  8. Merit Medical Systems Inc.
  9. DePuy Synthes
  10. KANEKA CORPORATION            

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports